GRI Bio (GRI) Fundamental Analysis: Revenue, Earnings & Valuation

0.94 / 10

Underperform

The company's fundamental score is low at 0.9/10. Key positives include an interest-coverage ratio of 66.08% and robust revenue growth (105.67% YoY). However, a high days-sales-outstanding of 148.87 days and minimal operating margins raise concerns. These mixed signals lead to a prudent, underperform evaluation.

Analysis Checks(3/4)

Total operating revenue (YoY growth rate %)

Value105.67

Score2/3

Weight-119.73%

1M Return1.11%

Days sales outstanding

Value148.87

Score1/3

Weight154.05%

1M Return-1.57%

Interest coverage ratio (EBIT / Interest expense) (%)

Value66.08

Score2/3

Weight111.81%

1M Return-1.11%

Operating revenue (YoY growth rate %)

Value137.95

Score2/3

Weight-46.13%

1M Return0.43%

Is GRI fundamentally strong?

GRI scores 0.94/10 on fundamentals and holds a Premium valuation at present. Backed by its -238.17% ROE, 0.00% net margin, -0.29 P/E ratio, 0.57 P/B ratio, and 92.12% earnings growth, these metrics solidify its Underperform investment rating.